-
Mashup Score: 0Prostate Cancer Focus 2021 - 3 year(s) agoSource: cloud.3dissue.netCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Prostate Cancer Focus 2021 - 3 year(s) agoSource: cloud.3dissue.netCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Prostate Cancer Focus 2021 - 3 year(s) agoSource: cloud.3dissue.netCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
A streamline procedure allows treatment with the NanoTherm therapy system for focal ablation to be completed within 1 day.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
A streamline procedure allows treatment with the NanoTherm therapy system for focal ablation to be completed within 1 day.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Focal therapy trials - 3 year(s) ago
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer that is at intermediate or high risk of progression, while low risk men should be offered active…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Focal therapy trials - 3 year(s) ago
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer that is at intermediate or high risk of progression, while low risk men should be offered active…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Focal therapy trials - 3 year(s) ago
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer that is at intermediate or high risk of progression, while low risk men should be offered active…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Focal therapy trials - 3 year(s) ago
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer that is at intermediate or high risk of progression, while low risk men should be offered active…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Focal therapy trials - 4 year(s) ago
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer that is at intermediate or high risk of progression, while low risk men should be offered active…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
Focal therapies in localised prostate cancer by Matthew Deacon and @gordonhmuir. Read their article in full for free here in our exclusive prostate cancer focus digital supplement > https://t.co/1fa9BiSSxR #focaltherapy #prostatecancer https://t.co/INAmIEZjK0